Literature DB >> 9402469

The stimulatory effect of rabphilin 3a on regulated exocytosis from insulin-secreting cells does not require an association-dissociation cycle with membranes mediated by Rab 3.

M Arribas1, R Regazzi, E Garcia, C B Wollheim, P De Camilli.   

Abstract

Rabphilin 3a is a Rab 3-GTP binding protein concentrated on secretory vesicles of neurons and endocrine cells. There is evidence that rabphilin 3a undergoes cycles of association-dissociation with membranes and that recruitment of rabphilin 3a to secretory vesicles is mediated by Rab 3a, suggesting that rabphilin 3a is a downstream effector of this Rab. In this study we have investigated whether a membrane-anchored form of rabphilin 3a mimics the action of rabphilin 3a on secretion and bypasses the need for Rab 3 function. Overexpression of both wild-type rabphilin 3a and of a transmembrane anchored form of rabphilin 3a stimulated (about 2-fold) evoked secretion of coexpressed human proinsulin from clonal HIT-T15 cells. A similar transmembrane-anchored protein which lacked the Rab 3 binding region stimulated secretion even more effectively. Unexpectedly, a rabphilin 3a deletion mutant missing the Rab 3 binding domain was also stimulatory on secretion, although a further deletion of rabphilin to exclude the first of the two proline-rich regions abolished its stimulatory effect. The first of these two mutants was primarily particulate, while the second mutant was primarily soluble, suggesting that the first proline-rich region of rabphilin 3a plays a role in targeting rabphilin to its site of action. We conclude that the action of rabphilin 3a can be independent of Rab 3 if other mechanisms produce a sufficient concentration of the protein in proximity of exocytotic sites. These results provide new evidence for a fundamental similarity in the mechanisms by which Ras and Rab GTPase produce their distinct physiological effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402469

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  7 in total

1.  Androgen receptor-deficient islet β-cells exhibit alteration in genetic markers of insulin secretion and inflammation. A transcriptome analysis in the male mouse.

Authors:  Weiwei Xu; Tianhua Niu; Beibei Xu; Guadalupe Navarro; Matthew J Schipma; Franck Mauvais-Jarvis
Journal:  J Diabetes Complications       Date:  2017-03-09       Impact factor: 2.852

2.  Physiological modulation of rabphilin phosphorylation.

Authors:  D L Foletti; J T Blitzer; R H Scheller
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

3.  Developmental regulation and specific brain distribution of phosphorabphilin.

Authors:  D L Foletti; R H Scheller
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

4.  Rabphilin knock-out mice reveal that rabphilin is not required for rab3 function in regulating neurotransmitter release.

Authors:  O M Schlüter; E Schnell; M Verhage; T Tzonopoulos; R A Nicoll; R Janz; R C Malenka; M Geppert; T C Südhof
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

Review 5.  Emerging role of testosterone in pancreatic β-cell function and insulin secretion.

Authors:  Weiwei Xu; Jamie Morford; Franck Mauvais-Jarvis
Journal:  J Endocrinol       Date:  2019-01-01       Impact factor: 4.286

6.  PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice.

Authors:  José Iglesias; Sebastian Barg; David Vallois; Shawon Lahiri; Catherine Roger; Akadiri Yessoufou; Sylvain Pradevand; Angela McDonald; Claire Bonal; Frank Reimann; Fiona Gribble; Marie-Bernard Debril; Daniel Metzger; Pierre Chambon; Pedro Herrera; Guy A Rutter; Marc Prentki; Bernard Thorens; Walter Wahli
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

7.  Rabphilin potentiates soluble N-ethylmaleimide sensitive factor attachment protein receptor function independently of rab3.

Authors:  J Staunton; B Ganetzky; M L Nonet
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.